Skip to main content

Check out this JAMA Network video on monoclonal antibodies as a potential treatment for patients with COVID-19, featuring Myron Cohen, MD, director of the UNC Institute for Global Health and Infectious Diseases, and Francis Collins, MD, PhD, director of the National Institutes of Health.


Neutralizing monoclonal antibodies (mAbs) may be a highly effective way to treat and prevent COVID-19 while waiting for a vaccine. Watch this video featuring UNC School of Medicine alum Francis Collins, MD, PhD, Director of the National Institutes of Health, and Myron Cohen, MD, Director of the UNC Institute for Global Health and Infectious Diseases, to find out how these drugs are created and how they target the SARS-CoV-2 virus.

Also, check out the related JAMA viewpoint co-authored by Dr. Cohen.